NeuroSense strives to make science, research and clinical development accessible to patients, family members, caregivers, and the scientific community. Therefore, we have created a blog that will touch upon different aspects of drug development, neurodegenerative diseases, research and development, science, biotech and business. Check this page regularly for informative and timely updates.
How are new medications created? How does an idea for a treatment lead to the development of a product? How do you choose the right target and optimal mechanisms of action?
Amyotrophic lateral sclerosis (ALS) is a complex disease with multiple interacting pathologies, that presents itself differently in each patient